Diversity, Equity, and Inclusion Data Service for clinical development
Drug Discovery World
SEPTEMBER 6, 2023
Phesi, a global provider of patient-centric data software and services, has partnered with Krystelis, a provider of medical writing and clinical trial transparency services, to launch its new Diversity, Equity, and Inclusion (DEI) Data Service. A 2022 Phesi data analysis discovered 42% of US cancer trial cohorts do not include African American patients, and almost half – 48% – have no Hispanic American patients.
Let's personalize your content